These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 20465389)

  • 1. Clinical outcomes in non-small-cell lung cancer in relation to expression of predictive and prognostic biomarkers.
    Singh N; Bal A; Aggarwal AN; Das A; Behera D
    Future Oncol; 2010 May; 6(5):741-67. PubMed ID: 20465389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of betaIII tubulin in predicting chemoresistance in non-small cell lung cancer.
    Sève P; Reiman T; Dumontet C
    Lung Cancer; 2010 Feb; 67(2):136-43. PubMed ID: 19828208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytotoxic chemotherapy in advanced non-small cell lung cancer: a review of standard treatment paradigms.
    Socinski MA
    Clin Cancer Res; 2004 Jun; 10(12 Pt 2):4210s-4214s. PubMed ID: 15217960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted therapies for non-small cell lung cancer.
    Dempke WC; Suto T; Reck M
    Lung Cancer; 2010 Mar; 67(3):257-74. PubMed ID: 19914732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Individualized therapy for patients with non-small cell lung cancer: emerging trends and challenges.
    Langer CJ
    Crit Rev Oncol Hematol; 2012 Jul; 83(1):130-44. PubMed ID: 22280915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Possibilities and limitations of stratified medicine based on biomarkers and targeted therapies in oncology].
    Ludwig WD
    Z Evid Fortbild Qual Gesundhwes; 2012; 106(1):11-22. PubMed ID: 22325103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Personalized, targeted treatment of non-small cell lung cancer].
    Wolf J
    Dtsch Med Wochenschr; 2011 Mar; 136(10):480-5. PubMed ID: 21365525
    [No Abstract]   [Full Text] [Related]  

  • 8. Erlotinib: small-molecule targeted therapy in the treatment of non-small-cell lung cancer.
    Smith J
    Clin Ther; 2005 Oct; 27(10):1513-34. PubMed ID: 16330289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New agents in advanced non-small-cell lung cancer treatment.
    Ricciardi S; de Marinis F
    Oncology; 2009; 77 Suppl 1():103-12. PubMed ID: 20130438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The emerging role of biomarkers in advanced non-small-cell lung cancer.
    Socinski MA
    Clin Lung Cancer; 2010 May; 11(3):149-59. PubMed ID: 20439190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoclonal antibodies in lung cancer.
    Wang Y; Deng G; Liu X; Cho WC
    Expert Opin Biol Ther; 2013 Feb; 13(2):209-26. PubMed ID: 23240766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular predictors of response to chemotherapy in non-small cell lung cancer.
    Andrews J; Yeh P; Pao W; Horn L
    Cancer J; 2011; 17(2):104-13. PubMed ID: 21427554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemotherapy for lung cancer: the state of the art in 2009.
    Higgins MJ; Ettinger DS
    Expert Rev Anticancer Ther; 2009 Oct; 9(10):1365-78. PubMed ID: 19827996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EGF receptor in lung cancer: a successful story of targeted therapy.
    Domingo G; Perez CA; Velez M; Cudris J; Raez LE; Santos ES
    Expert Rev Anticancer Ther; 2010 Oct; 10(10):1577-87. PubMed ID: 20942629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Personalized medicine in the treatment of advanced nonsmall cell lung cancer: step-by-step progress.
    Gridelli C
    Curr Opin Oncol; 2012 Mar; 24(2):115-6. PubMed ID: 22123236
    [No Abstract]   [Full Text] [Related]  

  • 16. Influence of histology and biomarkers on first-line treatment of advanced non-small cell lung cancer in routine care setting: baseline results of an observational study (FRAME).
    Schnabel PA; Smit E; Carpeño Jde C; Leśniewski-Kmak K; Aerts J; Kraaij K; Visseren-Grul C; Dyachkova Y; Taipale K; Girvan A; Moro-Sibilot D
    Lung Cancer; 2012 Dec; 78(3):263-9. PubMed ID: 23040326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gefitinib as first-line treatment for patients with advanced non-small-cell lung cancer with activating epidermal growth factor receptor mutation: Review of the evidence.
    Gridelli C; De Marinis F; Di Maio M; Cortinovis D; Cappuzzo F; Mok T
    Lung Cancer; 2011 Mar; 71(3):249-57. PubMed ID: 21216486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current treatments for advanced stage non-small cell lung cancer.
    Stinchcombe TE; Socinski MA
    Proc Am Thorac Soc; 2009 Apr; 6(2):233-41. PubMed ID: 19349493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pemetrexed for the treatment of non-small-cell lung cancer.
    Manegold C; Schmid-Bindert G; Pilz LR
    Expert Rev Anticancer Ther; 2009 Sep; 9(9):1195-209. PubMed ID: 19761423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is there a role for maintenance therapy in non-small-cell lung cancer? An emerging issue.
    Petrelli F; Ghilardi M; Cremonesi M; Cabiddu M; Barni S
    Expert Rev Anticancer Ther; 2009 Oct; 9(10):1455-65. PubMed ID: 19828007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.